Logo image of YTSN.DE

KUROS BIOSCIENCES AG-REG (YTSN.DE) Stock Price, Quote, News and Overview

FRA:YTSN - Deutsche Boerse Ag - CH0325814116 - Common Stock - Currency: EUR

30.7  -0.56 (-1.79%)

YTSN.DE Quote, Performance and Key Statistics

KUROS BIOSCIENCES AG-REG

FRA:YTSN (7/18/2025, 7:00:00 PM)

30.7

-0.56 (-1.79%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap1.18B
Shares38.54M
Float27.63M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-13 2025-08-13
IPO10-29 2002-10-29


YTSN.DE short term performance overview.The bars show the price performance of YTSN.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8 10

YTSN.DE long term performance overview.The bars show the price performance of YTSN.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of YTSN.DE is 30.7 EUR.

KUROS BIOSCIENCES AG-REG / YTSN Daily stock chart

YTSN.DE Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 18.53 288.63B
AMG.DE AMGEN INC 14.3 137.04B
GIS.DE GILEAD SCIENCES INC 14.12 116.61B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 102.50B
ARGX.BR ARGENX SE 107.19 30.04B
22UA.DE BIONTECH SE-ADR N/A 22.69B
IDP.DE BIOGEN INC 7.99 15.90B
0QF.DE MODERNA INC N/A 10.56B
1MRNA.MI MODERNA INC N/A 10.54B
1VKTX.MI VIKING THERAPEUTICS INC N/A 3.00B
GLPG.AS GALAPAGOS NV N/A 1.77B
5CV.DE CUREVAC NV 5.72 1.04B

About YTSN.DE

Company Profile

YTSN logo image Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. The company is headquartered in Schlieren, Zuerich and currently employs 122 full-time employees. The company went IPO on 2002-10-29. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic diseases, asthma, malignant melanoma and Alzheimer's disease. They are designed to instruct the patient's immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. The firm has built a pipeline of different Immunodrug candidates, of which five are in clinical development. Its Immunodrug candidates are developed both in-house and together with Novartis, Pfizer and Pfizer Animal Health, among others. The firm has two subsidiaries: a wholly-owned Proteome Therapeutics GmbH and minority owned BioSupport AG.

Company Info

KUROS BIOSCIENCES AG-REG

Wagistrasse 25

Schlieren ZUERICH CH

Employees: 122

YTSN Company Website

YTSN Investor Relations

Phone: 41447334747

KUROS BIOSCIENCES AG-REG / YTSN.DE FAQ

What is the stock price of KUROS BIOSCIENCES AG-REG today?

The current stock price of YTSN.DE is 30.7 EUR. The price decreased by -1.79% in the last trading session.


What is the ticker symbol for KUROS BIOSCIENCES AG-REG stock?

The exchange symbol of KUROS BIOSCIENCES AG-REG is YTSN and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is YTSN.DE stock listed?

YTSN.DE stock is listed on the Deutsche Boerse Ag exchange.


What is KUROS BIOSCIENCES AG-REG worth?

KUROS BIOSCIENCES AG-REG (YTSN.DE) has a market capitalization of 1.18B EUR. This makes YTSN.DE a Small Cap stock.


How many employees does KUROS BIOSCIENCES AG-REG have?

KUROS BIOSCIENCES AG-REG (YTSN.DE) currently has 122 employees.


Should I buy KUROS BIOSCIENCES AG-REG (YTSN.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does KUROS BIOSCIENCES AG-REG (YTSN.DE) stock pay dividends?

YTSN.DE does not pay a dividend.


When does KUROS BIOSCIENCES AG-REG (YTSN.DE) report earnings?

KUROS BIOSCIENCES AG-REG (YTSN.DE) will report earnings on 2025-08-13.


What is the Price/Earnings (PE) ratio of KUROS BIOSCIENCES AG-REG (YTSN.DE)?

KUROS BIOSCIENCES AG-REG (YTSN.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).


YTSN.DE Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to YTSN.DE.


Chartmill TA Rating
Chartmill Setup Rating

YTSN.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to YTSN.DE. No worries on liquidiy or solvency for YTSN.DE as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

YTSN.DE Financial Highlights

Over the last trailing twelve months YTSN.DE reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS increased by 69.49% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -5.07%
ROE -7.3%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%57.07%
Sales Q2Q%111.18%
EPS 1Y (TTM)69.49%
Revenue 1Y (TTM)142.5%

YTSN.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 86% to YTSN.DE. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners14.84%
Ins Owners1.9%
Short Float %N/A
Short RatioN/A
Analysts
Analysts85.71
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A